home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
from the press
governance
stock chart
Contact
Menu
home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
from the press
governance
stock chart
Contact
Investor relations
Investors lobby
company profile
press releases
presentations
events
from the press
governance
stock chart
Sec Fillings
Contact
Menu
Investors lobby
company profile
press releases
presentations
events
from the press
governance
stock chart
Sec Fillings
Contact
press releases
05/18/2023
PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
read more
05/15/2023
PainReform Provides Business Update for the First Quarter of 2023
read more
05/02/2023
PainReform CEO to Present at Aegis Virtual Conference on May 4th
read more
05/01/2023
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trialof PRF-110 in Patients Undergoing Bunionectomy Surgery
read more
03/28/2023
PainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy Surgery
read more
03/16/2023
PainReform Provides Year-End Business Update; Commences Phase 3 Clinical Trial of PRF-110 in Bunionectomy
read more
